Tamoxifen
Tamoxifen market is segmented by region (country), players, by Type and by Application. Players, ... Read More
Global and United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Report & Forecast 2023-2028
1 Study Coverage
1.1 Tenofovir Disoproxil Fumarate and Its Combination Drugs Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size for the Year 2017-2028
1.2.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size for the Year 2017-2028
1.3 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Tenofovir Disoproxil Fumarate and Its Combination Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Dynamics
1.4.1 Tenofovir Disoproxil Fumarate and Its Combination Drugs Industry Trends
1.4.2 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Drivers
1.4.3 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Challenges
1.4.4 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Tenofovir Disoproxil Fumarate and Its Combination Drugs by Type
2.1 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Segment by Type
2.1.1 Tenofovir Disoproxil Fumarate
2.1.2 Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine
2.1.3 Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine
2.1.4 Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine
2.1.5 Tenofovir Disoproxil Fumarate/Emtricitabine
2.1.6 Lamivudine/Tenofovir Disoproxil Fumarate
2.1.7 Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate
2.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type (2017-2028)
2.4 United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type (2017-2028)
3 Tenofovir Disoproxil Fumarate and Its Combination Drugs by Application
3.1 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Drug Center
3.1.4 Other
3.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application (2017-2028)
3.4 United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application (2017-2028)
4 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Competitor Landscape by Company
4.1 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Company
4.1.1 Top Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Revenue by Player (2017-2022)
4.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Concentration Ratio (CR)
4.2.1 Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Tenofovir Disoproxil Fumarate and Its Combination Drugs in 2021
4.2.3 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Headquarters, Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Headquarters and Area Served
4.3.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Companies Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Tenofovir Disoproxil Fumarate and Its Combination Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Company
4.5.1 Top Tenofovir Disoproxil Fumarate and Its Combination Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Region
5.1 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Region (2017-2028)
5.2.1 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Region: 2017-2022
5.2.2 Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Alkem Laboratories
7.1.1 Alkem Laboratories Company Details
7.1.2 Alkem Laboratories Business Overview
7.1.3 Alkem Laboratories Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.1.4 Alkem Laboratories Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.1.5 Alkem Laboratories Recent Development
7.2 Anhui Biochem Pharmaceutical
7.2.1 Anhui Biochem Pharmaceutical Company Details
7.2.2 Anhui Biochem Pharmaceutical Business Overview
7.2.3 Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.2.4 Anhui Biochem Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.2.5 Anhui Biochem Pharmaceutical Recent Development
7.3 Beijing SL Pharmaceutical
7.3.1 Beijing SL Pharmaceutical Company Details
7.3.2 Beijing SL Pharmaceutical Business Overview
7.3.3 Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.3.4 Beijing SL Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.3.5 Beijing SL Pharmaceutical Recent Development
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Details
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.4.4 Bristol-Myers Squibb Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.4.5 Bristol-Myers Squibb Recent Development
7.5 Chengdu Brilliant Pharmaceutical
7.5.1 Chengdu Brilliant Pharmaceutical Company Details
7.5.2 Chengdu Brilliant Pharmaceutical Business Overview
7.5.3 Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.5.4 Chengdu Brilliant Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.5.5 Chengdu Brilliant Pharmaceutical Recent Development
7.6 CHIA TAI TIANQING (CTTQ) Pharmaceutical
7.6.1 CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Details
7.6.2 CHIA TAI TIANQING (CTTQ) Pharmaceutical Business Overview
7.6.3 CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.6.4 CHIA TAI TIANQING (CTTQ) Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.6.5 CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development
7.7 Cipla
7.7.1 Cipla Company Details
7.7.2 Cipla Business Overview
7.7.3 Cipla Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.7.4 Cipla Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.7.5 Cipla Recent Development
7.8 Cisen Pharmaceutical
7.8.1 Cisen Pharmaceutical Company Details
7.8.2 Cisen Pharmaceutical Business Overview
7.8.3 Cisen Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.8.4 Cisen Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.8.5 Cisen Pharmaceutical Recent Development
7.9 Dr Reddy's Laboratories
7.9.1 Dr Reddy's Laboratories Company Details
7.9.2 Dr Reddy's Laboratories Business Overview
7.9.3 Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.9.4 Dr Reddy's Laboratories Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.9.5 Dr Reddy's Laboratories Recent Development
7.10 Emcure Pharmaceuticals
7.10.1 Emcure Pharmaceuticals Company Details
7.10.2 Emcure Pharmaceuticals Business Overview
7.10.3 Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.10.4 Emcure Pharmaceuticals Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.10.5 Emcure Pharmaceuticals Recent Development
7.11 Fujian Cosunter Pharmaceutical
7.11.1 Fujian Cosunter Pharmaceutical Company Details
7.11.2 Fujian Cosunter Pharmaceutical Business Overview
7.11.3 Fujian Cosunter Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.11.4 Fujian Cosunter Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.11.5 Fujian Cosunter Pharmaceutical Recent Development
7.12 Gilead Sciences
7.12.1 Gilead Sciences Company Details
7.12.2 Gilead Sciences Business Overview
7.12.3 Gilead Sciences Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.12.4 Gilead Sciences Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.12.5 Gilead Sciences Recent Development
7.13 GlaxoSmithKline
7.13.1 GlaxoSmithKline Company Details
7.13.2 GlaxoSmithKline Business Overview
7.13.3 GlaxoSmithKline Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.13.4 GlaxoSmithKline Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.13.5 GlaxoSmithKline Recent Development
7.14 Haisco Pharmaceutical
7.14.1 Haisco Pharmaceutical Company Details
7.14.2 Haisco Pharmaceutical Business Overview
7.14.3 Haisco Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.14.4 Haisco Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.14.5 Haisco Pharmaceutical Recent Development
7.15 Hetero Drugs
7.15.1 Hetero Drugs Company Details
7.15.2 Hetero Drugs Business Overview
7.15.3 Hetero Drugs Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.15.4 Hetero Drugs Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.15.5 Hetero Drugs Recent Development
7.16 Janssen Pharmaceutica (Johnson & Johnson)
7.16.1 Janssen Pharmaceutica (Johnson & Johnson) Company Details
7.16.2 Janssen Pharmaceutica (Johnson & Johnson) Business Overview
7.16.3 Janssen Pharmaceutica (Johnson & Johnson) Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.16.4 Janssen Pharmaceutica (Johnson & Johnson) Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.16.5 Janssen Pharmaceutica (Johnson & Johnson) Recent Development
7.17 Mylan Pharmaceuticals
7.17.1 Mylan Pharmaceuticals Company Details
7.17.2 Mylan Pharmaceuticals Business Overview
7.17.3 Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.17.4 Mylan Pharmaceuticals Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.17.5 Mylan Pharmaceuticals Recent Development
7.18 Natco Pharma
7.18.1 Natco Pharma Company Details
7.18.2 Natco Pharma Business Overview
7.18.3 Natco Pharma Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.18.4 Natco Pharma Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.18.5 Natco Pharma Recent Development
7.19 Qilu Pharmaceutical
7.19.1 Qilu Pharmaceutical Company Details
7.19.2 Qilu Pharmaceutical Business Overview
7.19.3 Qilu Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.19.4 Qilu Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.19.5 Qilu Pharmaceutical Recent Development
7.20 Sun Pharmaceutical Industries
7.20.1 Sun Pharmaceutical Industries Company Details
7.20.2 Sun Pharmaceutical Industries Business Overview
7.20.3 Sun Pharmaceutical Industries Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.20.4 Sun Pharmaceutical Industries Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.20.5 Sun Pharmaceutical Industries Recent Development
7.21 Teva
7.21.1 Teva Company Details
7.21.2 Teva Business Overview
7.21.3 Teva Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.21.4 Teva Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.21.5 Teva Recent Development
7.22 Torrent Pharmaceuticals
7.22.1 Torrent Pharmaceuticals Company Details
7.22.2 Torrent Pharmaceuticals Business Overview
7.22.3 Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.22.4 Torrent Pharmaceuticals Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.22.5 Torrent Pharmaceuticals Recent Development
7.23 United Laboratories
7.23.1 United Laboratories Company Details
7.23.2 United Laboratories Business Overview
7.23.3 United Laboratories Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.23.4 United Laboratories Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.23.5 United Laboratories Recent Development
7.24 Veritaz Healthcare
7.24.1 Veritaz Healthcare Company Details
7.24.2 Veritaz Healthcare Business Overview
7.24.3 Veritaz Healthcare Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.24.4 Veritaz Healthcare Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.24.5 Veritaz Healthcare Recent Development
7.25 Wockhardt Ltd
7.25.1 Wockhardt Ltd Company Details
7.25.2 Wockhardt Ltd Business Overview
7.25.3 Wockhardt Ltd Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.25.4 Wockhardt Ltd Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.25.5 Wockhardt Ltd Recent Development
7.26 Zydus Cadila
7.26.1 Zydus Cadila Company Details
7.26.2 Zydus Cadila Business Overview
7.26.3 Zydus Cadila Tenofovir Disoproxil Fumarate and Its Combination Drugs Introduction
7.26.4 Zydus Cadila Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
7.26.5 Zydus Cadila Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
List of Tables
Table 1. Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
Table 2. Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Trends
Table 3. Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Drivers
Table 4. Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Challenges
Table 5. Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Restraints
Table 6. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Tenofovir Disoproxil Fumarate and Its Combination Drugs Companies in Global Market, Ranking by Revenue (2021)
Table 11. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Revenue by Player, (US$ Million), 2017-2022
Table 12. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Revenue Share by Player, 2017-2022
Table 13. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs as of 2021)
Table 15. Top Players of Tenofovir Disoproxil Fumarate and Its Combination Drugs in Global Market, Headquarters and Area Served
Table 16. Companies Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million) Type
Table 17. Date of International Companies Enter into Tenofovir Disoproxil Fumarate and Its Combination Drugs Market
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Top Tenofovir Disoproxil Fumarate and Its Combination Drugs Players in United States Market, Ranking by Revenue (2021)
Table 20. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 21. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 22. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 23. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 24. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Forecast by Region (2023-2028) & (US$ Million)
Table 25. North America Tenofovir Disoproxil Fumarate and Its Combination Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 26. Asia Pacific Tenofovir Disoproxil Fumarate and Its Combination Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 27. Europe Tenofovir Disoproxil Fumarate and Its Combination Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 28. Latin Americaa Tenofovir Disoproxil Fumarate and Its Combination Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 29. Middle East and Africa Tenofovir Disoproxil Fumarate and Its Combination Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 30. Alkem Laboratories Company Details
Table 31. Alkem Laboratories Business Overview
Table 32. Alkem Laboratories Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 33. Alkem Laboratories Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 34. Alkem Laboratories Recent Development
Table 35. Anhui Biochem Pharmaceutical Company Details
Table 36. Anhui Biochem Pharmaceutical Business Overview
Table 37. Anhui Biochem Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 38. Anhui Biochem Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 39. Anhui Biochem Pharmaceutical Recent Development
Table 40. Beijing SL Pharmaceutical Company Details
Table 41. Beijing SL Pharmaceutical Business Overview
Table 42. Beijing SL Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 43. Beijing SL Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 44. Beijing SL Pharmaceutical Recent Development
Table 45. Bristol-Myers Squibb Company Details
Table 46. Bristol-Myers Squibb Business Overview
Table 47. Bristol-Myers Squibb Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 48. Bristol-Myers Squibb Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 49. Bristol-Myers Squibb Recent Development
Table 50. Chengdu Brilliant Pharmaceutical Company Details
Table 51. Chengdu Brilliant Pharmaceutical Business Overview
Table 52. Chengdu Brilliant Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 53. Chengdu Brilliant Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 54. Chengdu Brilliant Pharmaceutical Recent Development
Table 55. CHIA TAI TIANQING (CTTQ) Pharmaceutical Company Details
Table 56. CHIA TAI TIANQING (CTTQ) Pharmaceutical Business Overview
Table 57. CHIA TAI TIANQING (CTTQ) Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 58. CHIA TAI TIANQING (CTTQ) Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 59. CHIA TAI TIANQING (CTTQ) Pharmaceutical Recent Development
Table 60. Cipla Company Details
Table 61. Cipla Business Overview
Table 62. Cipla Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 63. Cipla Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 64. Cipla Recent Development
Table 65. Cisen Pharmaceutical Company Details
Table 66. Cisen Pharmaceutical Business Overview
Table 67. Cisen Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 68. Cisen Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 69. Cisen Pharmaceutical Recent Development
Table 70. Dr Reddy's Laboratories Company Details
Table 71. Dr Reddy's Laboratories Business Overview
Table 72. Dr Reddy's Laboratories Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 73. Dr Reddy's Laboratories Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 74. Dr Reddy's Laboratories Recent Development
Table 75. Emcure Pharmaceuticals Company Details
Table 76. Emcure Pharmaceuticals Business Overview
Table 77. Emcure Pharmaceuticals Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 78. Emcure Pharmaceuticals Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 79. Emcure Pharmaceuticals Recent Development
Table 80. Fujian Cosunter Pharmaceutical Company Details
Table 81. Fujian Cosunter Pharmaceutical Business Overview
Table 82. Fujian Cosunter Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 83. Fujian Cosunter Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 84. Fujian Cosunter Pharmaceutical Recent Development
Table 85. Gilead Sciences Company Details
Table 86. Gilead Sciences Business Overview
Table 87. Gilead Sciences Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 88. Gilead Sciences Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 89. Gilead Sciences Recent Development
Table 90. GlaxoSmithKline Company Details
Table 91. GlaxoSmithKline Business Overview
Table 92. GlaxoSmithKline Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 93. GlaxoSmithKline Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 94. GlaxoSmithKline Recent Development
Table 95. Haisco Pharmaceutical Company Details
Table 96. Haisco Pharmaceutical Business Overview
Table 97. Haisco Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 98. Haisco Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 99. Haisco Pharmaceutical Recent Development
Table 100. Hetero Drugs Company Details
Table 101. Hetero Drugs Business Overview
Table 102. Hetero Drugs Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 103. Hetero Drugs Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 104. Hetero Drugs Recent Development
Table 105. Janssen Pharmaceutica (Johnson & Johnson) Company Details
Table 106. Janssen Pharmaceutica (Johnson & Johnson) Business Overview
Table 107. Janssen Pharmaceutica (Johnson & Johnson) Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 108. Janssen Pharmaceutica (Johnson & Johnson) Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 109. Janssen Pharmaceutica (Johnson & Johnson) Recent Development
Table 110. Mylan Pharmaceuticals Company Details
Table 111. Mylan Pharmaceuticals Business Overview
Table 112. Mylan Pharmaceuticals Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 113. Mylan Pharmaceuticals Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 114. Mylan Pharmaceuticals Recent Development
Table 115. Natco Pharma Company Details
Table 116. Natco Pharma Business Overview
Table 117. Natco Pharma Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 118. Natco Pharma Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 119. Natco Pharma Recent Development
Table 120. Qilu Pharmaceutical Company Details
Table 121. Qilu Pharmaceutical Business Overview
Table 122. Qilu Pharmaceutical Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 123. Qilu Pharmaceutical Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 124. Qilu Pharmaceutical Recent Development
Table 125. Sun Pharmaceutical Industries Company Details
Table 126. Sun Pharmaceutical Industries Business Overview
Table 127. Sun Pharmaceutical Industries Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 128. Sun Pharmaceutical Industries Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 129. Sun Pharmaceutical Industries Recent Development
Table 130. Teva Company Details
Table 131. Teva Business Overview
Table 132. Teva Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 133. Teva Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 134. Teva Recent Development
Table 135. Torrent Pharmaceuticals Company Details
Table 136. Torrent Pharmaceuticals Business Overview
Table 137. Torrent Pharmaceuticals Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 138. Torrent Pharmaceuticals Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 139. Torrent Pharmaceuticals Recent Development
Table 140. United Laboratories Company Details
Table 141. United Laboratories Business Overview
Table 142. United Laboratories Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 143. United Laboratories Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 144. United Laboratories Recent Development
Table 145. Veritaz Healthcare Company Details
Table 146. Veritaz Healthcare Business Overview
Table 147. Veritaz Healthcare Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 148. Veritaz Healthcare Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 149. Veritaz Healthcare Recent Development
Table 150. Wockhardt Ltd Company Details
Table 151. Wockhardt Ltd Business Overview
Table 152. Wockhardt Ltd Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 153. Wockhardt Ltd Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 154. Wockhardt Ltd Recent Development
Table 155. Zydus Cadila Company Details
Table 156. Zydus Cadila Business Overview
Table 157. Zydus Cadila Tenofovir Disoproxil Fumarate and Its Combination Drugs Product
Table 158. Zydus Cadila Revenue in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022) & (US$ Million)
Table 159. Zydus Cadila Recent Development
Table 160. Research Programs/Design for This Report
Table 161. Key Data Information from Secondary Sources
Table 162. Key Data Information from Primary Sources
List of Figures
Figure 1. Tenofovir Disoproxil Fumarate and Its Combination Drugs Product Picture
Figure 2. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size 2017-2028 (US$ Million)
Figure 4. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size, (US$ Million), 2017 VS 2022 VS 2028
Figure 5. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size 2017-2028 (US$ Million)
Figure 6. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share in Global 2017-2028
Figure 7. Tenofovir Disoproxil Fumarate and Its Combination Drugs Report Years Considered
Figure 8. Product Picture of Tenofovir Disoproxil Fumarate
Figure 9. Product Picture of Efavirenz/Tenofovir Disoproxil Fumarate/Emtricitabine
Figure 10. Product Picture of Rilpivirine/Tenofovir Disoproxil Fumarate/Emtricitabine
Figure 11. Product Picture of Elvitegravir/Cobicistat/Tenofovir Disoproxil Fumarate/Emtricitabine
Figure 12. Product Picture of Tenofovir Disoproxil Fumarate/Emtricitabine
Figure 13. Product Picture of Lamivudine/Tenofovir Disoproxil Fumarate
Figure 14. Product Picture of Efavirenz/Lamivudine/Tenofovir Disoproxil Fumarate
Figure 15. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 17. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Type (2017-2028)
Figure 18. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Type in 2022 & 2028
Figure 19. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Type (2017-2028) & (US$ Million)
Figure 20. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Type (2017-2028)
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Clinic
Figure 23. Product Picture of Drug Center
Figure 24. Product Picture of Other
Figure 25. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Application in 2022 & 2028
Figure 26. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 27. Global Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Application (2017-2028)
Figure 28. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Application in 2022 & 2028
Figure 29. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size by Application (2017-2028) & (US$ Million)
Figure 30. United States Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Share by Application (2017-2028)
Figure 31. North America Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 32. U.S. Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 33. Canada Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 34. Europe Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 35. Germany Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 36. France Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 37. U.K. Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 38. Italy Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 39. Russia Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 40. Asia-Pacific Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 41. China Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 42. Japan Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 43. South Korea Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 44. India Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 45. Australia Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 46. Taiwan Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 47. Indonesia Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 48. Thailand Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 49. Malaysia Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 50. Philippines Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 51. Latin America Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 52. Mexico Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 53. Brazil Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 54. Argentina Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 55. Middle East & Africa Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate 2017-2028 (US$ Million)
Figure 56. Turkey Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 57. Saudi Arabia Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 58. U.A.E Tenofovir Disoproxil Fumarate and Its Combination Drugs Market Size Growth Rate (2017-2028) & (US$ Million)
Figure 59. Alkem Laboratories Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 60. Anhui Biochem Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 61. Beijing SL Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 63. Chengdu Brilliant Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 64. CHIA TAI TIANQING (CTTQ) Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 65. Cipla Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 66. Cisen Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 67. Dr Reddy's Laboratories Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 68. Emcure Pharmaceuticals Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 69. Fujian Cosunter Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 70. Gilead Sciences Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 71. GlaxoSmithKline Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 72. Haisco Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 73. Hetero Drugs Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 74. Janssen Pharmaceutica (Johnson & Johnson) Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 75. Mylan Pharmaceuticals Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 76. Natco Pharma Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 77. Qilu Pharmaceutical Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 78. Sun Pharmaceutical Industries Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 79. Teva Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 80. Torrent Pharmaceuticals Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 81. United Laboratories Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 82. Veritaz Healthcare Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 83. Wockhardt Ltd Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 84. Zydus Cadila Revenue Growth Rate in Tenofovir Disoproxil Fumarate and Its Combination Drugs Business (2017-2022)
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Alkem Laboratories Anhui Biochem Pharmaceutical Beijing SL Pharmaceutical Bristol-Myers Squibb Chengdu Brilliant Pharmaceutical CHIA TAI TIANQING (CTTQ) Pharmaceutical Cipla Cisen Pharmaceutical Dr Reddy's Laboratories Emcure Pharmaceuticals Fujian Cosunter Pharmaceutical Gilead Sciences GlaxoSmithKline Haisco Pharmaceutical Hetero Drugs Janssen Pharmaceutica (Johnson & Johnson) Mylan Pharmaceuticals Natco Pharma Qilu Pharmaceutical Sun Pharmaceutical Industries Teva Torrent Pharmaceuticals United Laboratories Veritaz Healthcare Wockhardt Ltd Zydus Cadila